Physician profile
Charles Ryan Vasquez
NPI 1801209580
$6,819.08
in general payments reported to CMS, 2019-2025
13 companies · $4,889 in 2025
The $4,889 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.50 · 2022: $129 · 2024: $1,767 · 2025: $4,889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,758 · Education: $2,145 · Travel and Lodging: $1,753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,757.67 |
| Education | $2,145.07 |
| Travel and Lodging | $1,753.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,313.64 | 2024-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Bolton Medical INC | $1,611.71 | 2025 | Treo Abdominal Stent-Graft System |
| Boston Scientific Corporation | $931.32 | 2022-2025 | General - Therapies, General - Vascular Intervention, Enroute Transcarotid Neuroprotection System |
| Endologix LLC | $711.68 | 2024-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System |
| Cook Medical LLC | $331.57 | 2025 | Zilver Ptx, Lunderquist, Zenith Spiral-Z |
| Terumo Medical Corporation | $272.25 | 2025 | Azur Cx Detachable |
| Cvrx, INC. | $166.34 | 2025 | Barostim Neo System |
| Penumbra, INC. | $165.14 | 2025 | Penumbra System |
| Shockwave Medical, INC | $131.60 | 2025 | |
| Amgen INC. | $115.69 | 2025 | Repatha |
| Intuitive Surgical, INC. | $34.50 | 2021 | |
| Davol INC. | $21.81 | 2025 | Arista |
| Integra Lifesciences Corporation | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Vasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.